Floatz logo

Heplisav-B

Hepatitis

National Heart, Lung, and Blood Institute (NHLBI)vaccinePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Hepatitis cohort.

Asset / SponsorPhaseRating
MIDAZOLAM
Erasme University Hospital
Phase 4BB
Meperidine
Erasme University Hospital
Phase 4BB
Orlistat
St. Louis University
Phase 4BB
Entecavir
Cttq
Phase 4BB
URSODEOXYCHOLIC ACID
West China Hospital
Phase 4BB

View all 31 →

Same molecule, other indications

Heplisav-B is also rated in:

hepatitis B virus infectionDormant
BB
Indicative ·
65 / 100
View asset →
liver disorderDormant
BB
Indicative ·
65 / 100
View asset →
cirrhosis of liverDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →